General Announcement::We enclose a communication pertaining to USFDA approval

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Aug-2017 19:19:01
Status
New
Announcement Sub Title
We enclose a communication pertaining to USFDA approval
Announcement Reference
SG170828OTHRVD4B
Submitted By (Co./ Ind. Name)
Shyam S. Bhartia
Designation
Chairman and Managing Director
Effective Date and Time of the event
28/08/2017 17:00:00
Description (Please provide a detailed description of the event in the box below)
We enclose a communication pertaining to USFDA approval

Attachments

JPL - USFDA approval - 28.08.2017.pdf
Total size =176K